Patents
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
08/2010
08/05/2010US20100197729 Therapeutic ((phenyl)imidazolyl)methylquinolinyl compounds
08/05/2010US20100197728 Crystalline form of a quinolinone-carboxamide compound
08/05/2010US20100197727 Quinoline Derivatives as Antibacterial Agents
08/05/2010US20100197726 Inhibitor of the differentiation of t cells into th1 cells
08/05/2010US20100197725 1-oxo-isoindoline-4-carboxamide and 1-oxo-1,2,3,4-tetrahydroisoquinoline-5-carboxamide derivatives, preparation and therapeutic use thereof
08/05/2010US20100197724 6.5 -pyrrolopiperidine tachykinin receptor antagonists
08/05/2010US20100197723 Bicyclic compounds and methods of making and using same
08/05/2010US20100197722 Treatment for basal cell carcinoma
08/05/2010US20100197721 PYRROLO [3, 4-h] ISOQUINOLINE COMPOUNDS AND METHODS FOR MODULATING GATED ION CHANNELS
08/05/2010US20100197720 Heteroaryl-substituted diazatricycloalkanes and methods of use thereof
08/05/2010US20100197719 Medicament compositions containing anticholinergically-effective compounds and betamimetics
08/05/2010US20100197718 Treatment of pediatric tumors
08/05/2010US20100197717 Treatment of pain, neuropathic pain, sleep disorders, psychological disorders, memory disorders, depression, jet lag; 5HT7 receptor ligand such as AS-19, aka (2S)-(+)-8-(1,3,5-trimethylpyrazolin-4-yl)-2-(dimethylamino)tetralin and opioid such as morphine
08/05/2010US20100197716 N-linked heterocyclic antagonists of p2y1 receptor useful in the treatment of thrombotic conditions
08/05/2010US20100197715 Piperidine derivatives
08/05/2010US20100197714 Spiro-pyrano-pyrazole derivatives
08/05/2010US20100197713 Butone derivatives useful as cooling agents
08/05/2010US20100197712 Use of dopamine stabilizers
08/05/2010US20100197711 Benzothiazole compounds
08/05/2010US20100197710 Methods Of Activating IRS-1 And AKT
08/05/2010US20100197709 Non-sedating barbiturate compounds as neuroprotective agents
08/05/2010US20100197708 Indole compounds
08/05/2010US20100197707 Platelet manipulation to reduce the incidence of and treat endovascular disease and its sequelae, to reduce the incidence of and treat arrhythmias and to reduce the incidence of malignancy
08/05/2010US20100197706 Derivatives of 1-oxo-1,2-dihydroisoquinoline-5-carboxamides and of 4-oxo-3,4-dihydroquinazoline-8-carboxamides, preparation thereof and application thereof in therapeutics
08/05/2010US20100197705 Quinazolinone Derivatives Useful as Vanilloid Antagonists
08/05/2010US20100197704 Pharmaceutical compositions and method for treating acute mania
08/05/2010US20100197703 N-sulfonyl thiazolylpiperazine derivatives and related n-sulfonyl heterocyclic derivatives for the treatment of neuro degenerative diseases
08/05/2010US20100197702 Ophthalmic composition with nitric oxide donor compound and method of forming and using same
08/05/2010US20100197701 Method of treating diabetes
08/05/2010US20100197700 5-ht7 receptor antagonists
08/05/2010US20100197699 I-OXA-3-Azaspiro (4.5) Decan-2-One And 1-OXA-3, 8-Diazaspiro (4.5) Decan-2-One Derivatives For The Treatment of Eating Disorders
08/05/2010US20100197698 5-phenyl-3-pyridazinone derivative
08/05/2010US20100197697 Piperidine derivatives as nk3 receptor antagonists
08/05/2010US20100197695 Antitumoral derivatives of et-743
08/05/2010US20100197694 Compositions and methods for treatment of diseases and conditions with increased vascular permeability
08/05/2010US20100197693 Novel benzenesulfonamides as calcium channel blockers
08/05/2010US20100197692 Bicyclic heteroaromatic compounds as inhibitors of stearoyl-coenzyme a delta-9 desaturase
08/05/2010US20100197691 Soluble epoxide hydrolase inhibitors, compositions containing such compounds and methods of treatment
08/05/2010US20100197690 Pyrimidinyl Pyridazinone Derivatives
08/05/2010US20100197689 Novel processes for the preparation of piperazinyl and diazapanyl benzamide derivatives
08/05/2010US20100197688 Epha4 rtk inhibitors for treatment of neurological and neurodegenerative disorders and cancer
08/05/2010US20100197687 Indoles Useful in the Treatment of Inflammation
08/05/2010US20100197686 Therapeutic compounds
08/05/2010US20100197685 Novel benzofuran type derivatives, a composition comprising the same for treating or preventing cognitive dysfunction and the use thereof
08/05/2010US20100197684 Substituted heterocyclic compounds
08/05/2010US20100197683 Fused ring compound and use thereof
08/05/2010US20100197682 Organic Compounds
08/05/2010US20100197681 Triazolopyridine Compounds and Their Use as Ask Inhibitors
08/05/2010US20100197680 Lactam-substituted dicarboxylic acids and use thereof
08/05/2010US20100197679 Compounds
08/05/2010US20100197678 Glucocorticoid Mimetics, Methods of Making Them, Pharmaceutical Compositions and Uses Thereof
08/05/2010US20100197677 Oxadiazoanthracene compounds for the treatment of diabetes
08/05/2010US20100197676 5-Substituted-2-Phenylamino Benzamides as Mek Inhibitors
08/05/2010US20100197675 Cyclic urea and carbamate inhibitors of 11 beta-hydroxysteroid dehydrogenase 1
08/05/2010US20100197673 Indole and indazole compounds as an inhibitor of cellular necrosis
08/05/2010US20100197672 Pyrrole compounds as inhibitors of mycobacteria, synthesis thereof and intermediates thereto
08/05/2010US20100197671 Phenyl amino pyrimidine compounds and uses thereof
08/05/2010US20100197670 Amidine, thiourea and guanidine derivatives of 2-aminobenzothiazoles and aminobenzothiazines for their use as pharmacological agents for the treatment of neurodegenerative pathologies
08/05/2010US20100197669 Kappa selective opioid receptor antagonist
08/05/2010US20100197668 1,2,3,4-TETRAHYDROPYRROLO[1,2-A]PYRAZINE-6-CARBOXAMIDE AND 2,3,4,5-TETRAHYDROPYRROLO[1,2-a][1,4]-DIAZEPINE-7-CARBOXAMIDE DERIVATIVES, PREPARATION AND THERAPEUTIC USE THEREOF
08/05/2010US20100197667 Biphenyl compounds useful as muscarinic receptor antagonists
08/05/2010US20100197666 (thio) -carbamoyl-cyclohexane derivatives and method for treating schizophrenia
08/05/2010US20100197665 Indazole derivatives as kinase inhibitors for the treatment of cancer
08/05/2010US20100197664 Novel b1-antagonists
08/05/2010US20100197663 Method and compositions for treatment of painful disorders
08/05/2010US20100197662 Heterocyclic compound having type i 11 beta hydroxysteroid dehydrogenase inhibitory activity
08/05/2010US20100197661 Method of Treating Neurological Diseases and Disorders
08/05/2010US20100197660 Azepine derivatives as gamma-secretase inhibitors
08/05/2010US20100197659 Biphenylcarboxamide derivatives as hedgehod pathway modulators
08/05/2010US20100197658 Pharmaceutical use of fused 1,2,4-triazoles
08/05/2010US20100197657 2-aryl or heteroaryl indole derivatives
08/05/2010US20100197656 Compounds for the treatment of inflammatory diseases
08/05/2010US20100197655 Sulfonamide derivatives
08/05/2010US20100197654 Triazine kinase inhibitors
08/05/2010US20100197653 Novel carbapenem derivatives
08/05/2010US20100197652 Pyridine carboxamide orexin receptor antagonists
08/05/2010US20100197651 Pyridazinone compounds
08/05/2010US20100197650 Compositions and methods of treatment comprising ceftaroline
08/05/2010US20100197649 Compositions and Methods for Diagnosing and Treating Community-Acquired Methicillin-Resistant Staphylococcus Aureus
08/05/2010US20100197648 Treatment of irritable bowel syndrome and related bowel disease
08/05/2010US20100197647 Compounds that inhibit oestrone sulphatase; compositions thereof; and methods employing the same
08/05/2010US20100197646 Solvent-based sterilisation of pharmaceuticals
08/05/2010US20100197645 Thioamide Derivatives as Progesterone Receptor Modulators
08/05/2010US20100197644 Chemical Compounds 572
08/05/2010US20100197643 Phytochemical-rich oils and methods related thereto
08/05/2010US20100197642 Slow release misoprostol for obstetric and/or gynaecological applications
08/05/2010US20100197641 Formulation for lipophilic agents
08/05/2010US20100197640 Novel sulfamoyl-phenyl-ureido compounds and their use as medicament
08/05/2010US20100197639 Methods and Devices for Analysis of X-Ray Images
08/05/2010US20100197638 Skin Beautifying Agent
08/05/2010US20100197637 Method of Treatment Using Bisphosphonic Acid
08/05/2010US20100197636 Injectable calcium-phosphate cement releasing a bone resorption inhibitor
08/05/2010US20100197635 Treatment of tardive dyskinesia with pyridoxal 5'-phosphate
08/05/2010US20100197634 Inhibitors of janus kinases
08/05/2010US20100197632 Anti-inflammatory dermatological composition comprising corticosteroids and hyaluronate fragments, and uses thereof
08/05/2010US20100197631 Hyaluronic acid derivatives containing groups able to release no
08/05/2010US20100197630 Cetp inhibitors derived from benzoxazole arylamides
08/05/2010US20100197629 Oral pharmaceutical solutions containing telbivudine
08/05/2010US20100197628 Methods of treating psychiatric, substance abuse, and other disorders using combinations containing omega-3 fatty acids
08/05/2010US20100197627 Pancreatic cancer treatment